# Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors

> **NCT00599924** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 53 (actual)

## Conditions studied

- Colorectal Neoplasms
- Neoplasms

## Interventions

- **DRUG:** sunitinib + FOLFOX
- **DRUG:** sunitinib + FOLFOX
- **DRUG:** sunitinib + FOLFOX
- **DRUG:** sunitinib + FOLFOX
- **DRUG:** sunitinib + FOLFOX
- **DRUG:** sunitinib + FOLFOX
- **DRUG:** sunitinib + FOLFOX

## Key facts

- **NCT ID:** NCT00599924
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2015-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00599924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00599924, "Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00599924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*